Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Giuseppe Roscilli
The Promise of Anti-ErbB3 Monoclonals as New Cancer Therapeutics
Oncotarget
Oncology
Intra-Tumor AvidinOX Allows Efficacy of Low Dose Systemic Biotinylated Cetuximab in a Model of Head and Neck Cancer
Oncotarget
Oncology
Related publications
Anti-Caveolin-1 Antibodies as Anti-Prostate Cancer Therapeutics
Hybridoma
An Evaluation of Minor Groove Binders as Anti-Lung Cancer Therapeutics
Bioorganic and Medicinal Chemistry Letters
Organic Chemistry
Molecular Medicine
Molecular Biology
Biochemistry
Clinical Biochemistry
Pharmaceutical Science
Drug Discovery
Estrogen-Related Receptor Alpha (ERRa)-Coactivator Interactions as Targets for Discovery of New Anti-Breast Cancer Therapeutics
Targeting ErbB3: The New RTK(id) on the Prostate Cancer Block
Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry
Immunology
Pharmacology
Endocrinology
Allergy
Metabolism
Diabetes
Driving Cancer Through ErbB3
Science-Business eXchange
Rapalogs and mTOR Inhibitors as Anti-Aging Therapeutics
Journal of Clinical Investigation
Medicine
ErbB Activation Signatures as Potential Biomarkers for Anti-ErbB3 Treatment in HNSCC
PLoS ONE
Multidisciplinary
Anti-Transcription Factor RNA Aptamers as Potential Therapeutics
Nucleic Acid Therapeutics
Biochemistry
Molecular Medicine
Drug Discovery
Genetics
Molecular Biology
Histone Deacetylase Inhibitors as Cancer Therapeutics
Annals of Translational Medicine
Medicine